About LumiraDx
LumiraDx is a Healthcare company based in Rotkreuz (Switzerland). LumiraDx is engaged in providing point-of-care diagnostic solutions. It operates on a Direct-to-Consumer (D2C) and Professional Services model. LumiraDx has completed 1 acquisition, including Analox. LumiraDx offers products and services including LumiraDx Instrument, NT-proBNP Test, and SARS-CoV-2 Antigen Test. Its focus areas include Medical Devices and Diagnostic Equipment.
Company details
LumiraDx is focused on delivering innovative point-of-care diagnostic solutions. The company offers portable, multimodal systems designed for efficient testing in decentralized settings like primary care. Its flagship product, the LumiraDx Instrument, supports rapid testing across various conditions including infectious diseases, cardiovascular issues, and diabetes with minimal training requirements. Solutions are provided for multiple sectors such as healthcare institutions, pharmacies, and community programs. The technology leverages actively controlled microfluidics to ensure reliable results in minutes, enhancing accessibility and clinical decision-making at the point of need.
- Headquarters Rotkreuz, Switzerland
- SectorsHealthcare
- Phone•••• ••••
- Website poct.co.uk
- Social LinkedIn X Facebook YouTube
- Investments & Acquisitions
Products & Services of LumiraDx
LumiraDx offers a comprehensive portfolio of products and services, including LumiraDx Instrument, NT-proBNP Test, and SARS-CoV-2 Antigen Test.
Portable device for rapid diagnostic testing at need.
Test for heart failure diagnosis using fingerstick sample.
Rapid test for detecting SARS-CoV-2 antigen presence.
Apps and channels of LumiraDx
its YouTube channel Roche has 20.8K subscribers and 30 videos.
Videos from LumiraDx
The most watched videos on LumiraDx's YouTube channel, Roche (20.8K subscribers). Click a video to play it here.
More on Roche.
Investments & Acquisitions by LumiraDx
LumiraDx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Analox.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer of analytical measurement systems | analox.com | Stourbridge, United Kingdom | 2015 | Feb 2015 | •••• |
Complete acquisition details for LumiraDx
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of LumiraDx
Websites that share an audience with LumiraDx (poct.co.uk).
Websites whose visitors overlap most with LumiraDx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abaxis.com | 100% | 2.2K | #7,093,547 | View details | |
| hemocue.com | 81% | 18.2K | #1,485,370 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LumiraDx
LumiraDx is headquartered in Rotkreuz, Switzerland. It is registered at Rotkreuz, Zug, Switzerland.
LumiraDx is focused on delivering innovative point-of-care diagnostic solutions. The company offers portable, multimodal systems designed for efficient testing in decentralized settings like primary care. Its flagship product, the LumiraDx Instrument, supports rapid testing across various conditions including infectious diseases, cardiovascular issues, and diabetes with minimal training requirements. Solutions are provided for multiple sectors such as healthcare institutions, pharmacies, and community programs. The technology leverages actively controlled microfluidics to ensure reliable results in minutes, enhancing accessibility and clinical decision-making at the point of need.
LumiraDx offers LumiraDx Instrument, NT-proBNP Test, and SARS-CoV-2 Antigen Test.
LumiraDx has made 1 acquisition, including Analox.